Skip to main content
OpenTrials

Clinical trial condition

Epilepsies, Partial

Explore clinical trials studying Epilepsies, Partial. Study availability and eligibility vary by location and protocol.

183 public trials 34 recruiting studies
Refine in advanced search Browse all conditions

Epilepsies, Partial trial results

Completed

Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures

NCT00275925

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +7 more
Locations
  • Epilepsy Department of the Moscow Research Institute of Psychiatry Moscow, Russia
  • Neurology and Neurosurgery Department of the Moscow State Medico-stomatology University Moscow, Russia
  • Neurology and Neurosurgery Department of the Russian State Medical University Moscow, Russia
  • Neurology Department of I.M. Sechenov Moscow Medical Academy Moscow, Russia
View Trial Details
Completed

To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

NCT00141245

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +3 more
Locations
  • Pfizer Investigational Site Deakin, Australian Capital Territory, Australia
  • Pfizer Investigational Site Chatswood, New South Wales, Australia
  • Pfizer Investigational Site Westmead, New South Wales, Australia
  • Pfizer Investigational Site Maroochydore, Queensland, Australia
View all 46 locations
View Trial Details
Completed

To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.

NCT00141414

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +3 more
Locations
  • Pfizer Investigational Site Little Rock, Arkansas, United States
  • Pfizer Investigational Site Los Angeles, California, United States
  • Pfizer Investigational Site Stanford, California, United States
  • Pfizer Investigational Site Miami, Florida, United States
View all 25 locations
View Trial Details
Completed

To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

NCT00141336

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +3 more
Locations
  • Pfizer Investigational Site Phoenix, Arizona, United States
  • Pfizer Investigational Site Tucson, Arizona, United States
  • Pfizer Investigational Site Bakersfield, California, United States
  • Pfizer Investigational Site Berkeley, California, United States
View all 103 locations
View Trial Details
Completed

Pregabalin Open-Label Extension Trial in Patients With Partial Seizures

NCT00143143

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +3 more
Locations
  • Pfizer Investigational Site Innsbruck, Austria
  • Pfizer Investigational Site Mauer bei Amstetten, Austria
  • Pfizer Investigational Site Sankt Pölten, Austria
  • Pfizer Investigational Site Vienna, Austria
View all 47 locations
View Trial Details
Active, Not Recruiting

Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

NCT06309966

Conditions
Brain Diseases, Central Nervous System Diseases, Drug Resistant Epilepsy, +8 more
Locations
  • Onyx Clinical Trials Peoria, Arizona, United States
  • Xenoscience, Inc. Phoenix, Arizona, United States
  • University of Arizona / Banner University Medical Center Phoenix Phoenix, Arizona, United States
  • ARENSIA Exploratory Medicine Phoenix, Arizona, United States
View all 152 locations
View Trial Details
Active, Not Recruiting

Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

NCT05067634

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +7 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Lucile Packard Children's Hospital Stanford Palo Alto, California, United States
  • University of California Davis Health Sacramento, California, United States
  • Connecticut Children's Medical Center Hartford, Connecticut, United States
View all 54 locations
View Trial Details

Related conditions